Ribon Therapeutics
Ribon Therapeutics is pioneering the discovery and development of monoPARP inhibitors. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$325m (Public information from Jan 2023)
Cambridge Massachusetts (HQ)
Authorizing premium user...